Erythropoietin stimulation decreases hepcidin expression through hematopoietic activity on bone marrow cells in mice

International Journal of Hematology

Volumn 96, Issue 6, 2012, Pages 692-700

  Sasaki, Yusuke ^a   Noguchi Sasaki, Mariko ^a   Yasuno, Hideyuki ^a   Yorozu, Keigo ^a   Shimonaka, Yasushi ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Bone marrow transplantation; Erythropoietin; Hepcidin; Iron metabolism

Indexed keywords

CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; HEMOGLOBIN; HEMOGLOBIN BETA CHAIN; HEPCIDIN; MESSENGER RNA; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HUMAN CARBAMYLATED ERYTHROPOIETIN BETA; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; CARBAMYLATED ERYTHROPOIETIN; DRUG DERIVATIVE; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL STIMULATION; COLONY FORMING CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ERYTHROCYTE; HEMATOPOIESIS; HEMOGLOBIN BLOOD LEVEL; HORMONAL REGULATION; HORMONE BLOOD LEVEL; IRON METABOLISM; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; WHOLE BODY RADIATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CLONOGENIC ASSAY; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; HUMAN; METABOLISM; RADIATION CHIMERA; RADIATION INJURY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; COLONY-FORMING UNITS ASSAY; DOWN-REGULATION; ERYTHROPOIESIS; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; RADIATION CHIMERA; RADIATION INJURIES, EXPERIMENTAL; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84875253909     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1217-4     Document Type: Article

References (30)

1. Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem. 1977;252:5558-64. (Pubitemid 8167007)
2. Jacobs K, Shoemaker C, Rudersdorf R, Neill SD, Kaufman RJ, Mufson A, et al. Isolation and characterization of genomic and cDNA clones of human erythropoietin. Nature. 1985;313:806-10. (Pubitemid 15130833)
3. Lin FK, Suggs S, Lin CH, Browne JK, Smalling R, Egrie JC, et al. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA. 1985;82:7580-4. (Pubitemid 16204391)
4. Foley RN. Emerging erythropoiesis-stimulating agents. Nat Rev Nephrol. 2010;6:218-23.
5. Macdougall IC. C.E.R.A., a once-monthly ESA: is it living up to expectations? Port L Nephrol Hypert. 2009;23:219-23.
6. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist. 2004;10:93-8. (Pubitemid 38372870)
7. Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, et al. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA. 2004;101:14907-12. (Pubitemid 39410773)
8. Ganz T, Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol. 2006;290:G199-203.
9. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090-3. (Pubitemid 40007660)
10. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr. 2006;26:323-42.
11. Otaki Y, Nakanishi T, Hasuike Y, Moriguchi R, Nanami M, Hama Y, et al. Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis. Am J Kidney Dis. 2004;43:1030-9. (Pubitemid 38691498)
12. Kuragano T, Shimonaka Y, Kida A, Furuta M, Nanami M, Otaki Y, et al. Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. Am J Nephrol. 2010;31:534-40.
13. Fein E, Merle U, Ehehalt R, Herrmann T, Kulaksiz H. Regulation of hepcidin in HepG2 and RINm5F cells. Peptides. 2007;28:951-7. (Pubitemid 46654432)
14. Pinto JP, Ribeiro S, Pontes H, Thowfeequ S, Tosh D, Carvalho F, et al. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha. Blood. 2008;111:5727-33.
15. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002;29:327-35.
16. Robach P, Recalcati S, Girelli D, Gelfi C, Aachmann-Andersen NJ, Thomsen JJ, et al. Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin. Blood. 2009;113:6707-15.
17. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica. 2010;95:505-8.
18. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. 2009;75:976-81.
19. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science. 2004;305:239-42. (Pubitemid 38886736)
20. Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom. 2007;21:4033-8.
21. Janssen WJ, Muldrow A, Kearns MT, Barthel L, Henson PM. Development and characterization of a lung-protective method of bone marrow transplantation in the mouse. J Immunol Methods. 2010;357:1-9.
22. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108:3730-5. (Pubitemid 44864551)
23. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res. 2006;55:667-74. (Pubitemid 46021227)
24. Jonckheere S, Dierick J, Vanhouteghem H, Devleeschouwer M, Stove V. Erythrocyte indices in the assessment of iron status in dialysis-dependent patients with end-stage renal disease on continuous erythropoietin receptor activator versus epoetin β therapy. Acta Haematol. 2010;124:27-33.
25. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, Lee YT, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med. 2007;13:1096-101. (Pubitemid 47517510)
26. Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, Bhupatiraju A, et al. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009;114:181-6.
27. Anderson GJ, Darshan D, Wilkins SJ, Frazer DM. Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals. 2007;20:665-74. (Pubitemid 46776558)
28. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271-6. (Pubitemid 39069926)
29. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA. 2005;102(6):1906-10. (Pubitemid 40261985)
30. Kanda J, Mizumoto C, Kawabata H, Tsuchida H, Tomosugi N, Matsuo K, et al. Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica. 2008;93:1550-4.